Eli Lilly and Company LLY
Regular-session close
After hours · Nov 13, 7:57 PM ET
- YTD
- +34.32%
- 1 year
- +41.12%
Discussion (582)
Sign in to join the discussion
Wait till RETA hits -3 X Agonist
In the Peptide world that's ALL people want. Game Changer. Zero food noise -no nausea. It will wipe out all others
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial- 2025
$LLY...AS I've said many times before...you don't sell this gem...it's simply utterly foolish to reduce LLY to just GLP-1...it has the best pipeline of all pharmaceutical stocks.
Just their pipeline all carries a high premium. Healthcare stocks are being sold off and cash is going into semi’s and AI. It’s so outta favor now
$LLY?
I POOP ON BEARTARD HEADS
$LLY...NOW, after a 23% correction, it's really starting to get ridiculous... what's the problem? Sales and results are excellent, as is the pipeline.
Earnings will be solid
Greetings from Germany
$LLY This shit drop everyday.?
$LLY...THIS is absolutely ridiculous..added 10 shares
$LLY..ADDED LLY&MCK ??
Greetings from Germany
$LLY..IT's getting ridiculous...added 15 shares
